Pharmacokinetics and dose selection of the 2-and 3-direct acting antiviral combination of AL-335 and odalasvir with/without simeprevir in hepatitis C virus-infected patients
HEPATOLOGY(2017)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined